White House Press Secretary Karine Jean-Pierre said that Biden was experiencing “mild symptoms" and has begun taking Paxlovid, an antiviral drug designed to reduce the severity of COVID-19.
She said Biden “will isolate at the White House and will continue to carry out all of his duties fully during that time."
Biden, 79, is fully vaccinated, after getting two doses of the Pfizer vaccine shortly before taking office, a first booster shot in September and an additional dose March 30.
Prior waves of the virus swept through Washington’s political class, infecting Vice President Kamala Harris, Cabinet members, White House staffers and lawmakers.
Biden has increasingly stepped up his travel schedule and resumed holding large indoor events where not everyone is tested.
When administered within five days of symptoms appearing, Paxlovid, produced by drugmaker Pfizer, has been proven to bring about a 90% reduction in hospitalizations and deaths among patients most likely to get severe disease.
In an April 30 speech to more than 2,600 attendees at the White House Correspondents’ Association dinner, Biden acknowledged the risks of attending large events, but said it was worthwhile to attend.
“I know there are questions about whether we should gather here tonight because of COVID,” he said. “Well, we’re here to show the country that we’re getting through this pandemic.”
Biden is not the first world leader — and not the first U.S. president — to get the coronavirus, which has infected British Prime Minister Boris Johnson, French President Emmanuel Macron and more than a dozen other leaders and high-ranking officials globally.
When Biden’s predecessor, President Donald Trump, contracted the disease in October 2020, vaccines were not available and treatment options were limited and less advanced. After being diagnosed with COVID-19 at the White House, Trump was given an experimental antibody treatment and steroids after his blood oxygen levels fell dangerously low. He was hospitalized at Walter Reed National Military Medical Center for three days.
While much of the world has resumed to a new normal after early lockdowns to control spikes in cases and deaths, the virus still serves as a disrupter in daily life as people are forced to change plans, isolate and calculate the risks of taking part in various activities.
